Cargando…
New-onset Seropositive Rheumatoid Arthritis Following COVID-19 Vaccination in a Patient with Seronegative Status
Coronavirus disease 2019 (COVID-19) has spread worldwide since 2019, and mRNA vaccines for the disease have been rapidly delivered to limit the severity of infection. However, while these vaccines are effective in reducing the morbidity and severity of the disease, some patients develop severe adver...
Autores principales: | Yonezawa, Haruka, Ohmura, Shin-ichiro, Ohkubo, Yusuke, Miyamoto, Toshiaki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Japanese Society of Internal Medicine
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9751727/ https://www.ncbi.nlm.nih.gov/pubmed/36070943 http://dx.doi.org/10.2169/internalmedicine.0257-22 |
Ejemplares similares
-
Seronegative and seropositive rheumatoid arthritis treated with rituximab
por: Velloso Feijoo, Maria Luisa, et al.
Publicado: (2012) -
Transient Pneumonitis as a Possible Adverse Reaction to the BNT162b2 COVID-19 mRNA Vaccine in a Patient with Rheumatoid Arthritis: A Case Report and Review of the Literature
por: Ohkubo, Yusuke, et al.
Publicado: (2022) -
Blood serotonin and joint pain in seropositive versus seronegative rheumatoid arthritis.
por: Kopp, Sigvard, et al.
Publicado: (2002) -
Clinical management of seronegative and seropositive rheumatoid arthritis: A comparative study
por: Choi, Sang-Tae, et al.
Publicado: (2018) -
Medium-vessel Vasculitis Presenting with Myalgia Following COVID-19 Moderna Vaccination
por: Ohmura, Shin-ichiro, et al.
Publicado: (2022)